Zelena Dóra, Földes Anna, Mergl Zsuzsa, Barna István, Kovács Krisztina J, Makara Gábor B
Institute of Experimental Medicine, Hungarian Academy of Sciences, Szigony 43, 1450 Pf. 67 Budapest 1083, Hungary.
Brain Res Bull. 2004 Jul 15;63(6):521-30. doi: 10.1016/j.brainresbull.2004.04.007.
Arginine-vasopressin (AVP) has been proposed to be an important mediator during chronic stress in the regulation of the hypothalamo-pituitary-adrenal axis. In the present study we addressed the role of AVP in maintaining adrenocortical responsiveness during chronic stress using the AVP deficient mutant Brattleboro rat. Heterozygous Brattleboro rats (di/+) served as controls and were compared to homozygous rats (di/di) with diabetes insipidus. Sixty minutes daily restraint was repeated for 5, 8, 11 or 15 days and organ weights, plasma adrenocorticotropin (ACTH) and corticosterone levels and anterior pituitary proopiomelanocortin (POMC) mRNA and ACTH content were measured. The body, adrenal and thymus weight changes induced by chronic stress became significant between 5 and 8 repetition and AVP deficiency had no effect on these parameters. The first indication that AVP has a role to play appears after 11 repetitions. In the di/di group at the end of 11th restraint, the plasma ACTH was decreased when compared to the di/+ rats. In animals with indwelling cannulas some adaptation could be seen in ACTH response without any difference between di/+ and di/di rats after 15 restraints. The corticosterone- and prolactin-elevations induced by restraint did not habituate in the di/+ and the di/di rats. Chronic stress increased POMC mRNA in the anterior pituitary similarly in di/+ and di/di rats. Although AVP seems to be necessary for a full ACTH response, most of the other signs of chronic stress after repeated restraint occur unchanged in the absence of AVP in both genders. This suggests that either AVP is not indispensable for activating the hypothalamo-pituitary-adrenocortical system by chronic stress or the absence of AVP is compensated by other mediators in Brattleboro rats.
精氨酸加压素(AVP)被认为是慢性应激期间下丘脑 - 垂体 - 肾上腺轴调节中的重要介质。在本研究中,我们使用AVP缺陷型突变布拉特洛维大鼠探讨了AVP在慢性应激期间维持肾上腺皮质反应性中的作用。杂合子布拉特洛维大鼠(di/+)作为对照,并与患有尿崩症的纯合子大鼠(di/di)进行比较。每天重复60分钟的束缚,持续5、8、11或15天,并测量器官重量、血浆促肾上腺皮质激素(ACTH)和皮质酮水平以及垂体前叶阿黑皮素原(POMC)mRNA和ACTH含量。慢性应激引起的体重、肾上腺和胸腺重量变化在重复5至8次时变得显著,而AVP缺乏对这些参数没有影响。AVP发挥作用的第一个迹象出现在重复11次之后。在第11次束缚结束时,di/di组的血浆ACTH与di/+大鼠相比有所下降。在有留置套管的动物中,在15次束缚后,ACTH反应中可以看到一些适应性变化,di/+和di/di大鼠之间没有差异。束缚诱导的皮质酮和催乳素升高在di/+和di/di大鼠中没有出现习惯化。慢性应激使di/+和di/di大鼠垂体前叶的POMC mRNA同样增加。虽然AVP似乎是完整ACTH反应所必需的,但在重复束缚后的大多数其他慢性应激迹象在两性缺乏AVP的情况下仍未改变。这表明,要么AVP对于慢性应激激活下丘脑 - 垂体 - 肾上腺皮质系统不是必不可少的,要么在布拉特洛维大鼠中AVP的缺失由其他介质补偿。